Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01128140 · ClinicalTrials.gov registry record · Phase 2
Efficacy Trial of Warrior Check-Up
A Phase 2 study, sponsored by University of Washington.
- Completed
- Registry status
- Phase 2
- Development phase
- 242
- Enrollment target
NCT01128140: Completed Phase 2 study, sponsored by University of Washington.
NCT01128140 is a Phase 2 study that has completed, run by University of Washington. The registered enrollment target is 242 participants, above the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target (82% higher). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01128140, a Phase 2 study, has completed, sponsored by University of Washington.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 242 participants
- Enrollment target
Study Summary
This study will develop and test a brief telephone-delivered motivational enhancement intervention for substance abusing military personnel who are not currently in treatment. The hypotheses being tested are that this intervention will prompt a willingness to participate voluntarily in a self-appraisal of substance abuse behavior and consequences, self-initiated change or enrollment in a treatment or self-help program, and cessation of abuse of alcohol or other drugs.
Primary Outcome
Structured interview that uses a timeline follow-back procedure to elicit detailed daily information on the use of alcohol and other drugs.
Interventions
- BEHAVIORAL Education
- BEHAVIORAL Motivational Enhancement Therapy
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 242 participants |
| Start Date | 2010-10 |
| Est. Completion | 2014-09 |
| Phase | Phase 2 |
What the finished NCT01128140 record still lists
NCT01128140 is an interventional study that assigns participants to a tested intervention. The registered 242 participants enrollment target is mid-sized for trials with a published cap, above the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target (82% higher).
The record links to 0 conditions, and to 2 interventions - of which Education is the first listed.
NCT01128140 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01128140 about?
NCT01128140 is a clinical study titled "Efficacy Trial of Warrior Check-Up". This study will develop and test a brief telephone-delivered motivational enhancement intervention for substance abusing military personnel who are not currently in treatment. The hypotheses being tested are that this intervention will prompt a willingness to participate voluntarily in a self-apprai...
What is the current status of trial NCT01128140?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 242 participants. The study started on 2010-10. Estimated completion is 2014-09.
What interventions are being tested in trial NCT01128140?
The interventions under investigation include: Education (BEHAVIORAL), Motivational Enhancement Therapy (BEHAVIORAL).
Who is sponsoring clinical trial NCT01128140?
This trial is sponsored by University of Washington, which has 1,048 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT01128140's enrollment target sits among peer trials
242 237th of 2000 higher than 1,762 of 2,000 other Phase 2 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 2 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03556228 · 242 participants · Phase 1
VMD-928 Monotherapy and in Combination With Pembrolizumab to Treat TrkA Overexpression Driven Solid Tumors or Lymphoma
- NCT04260022 · 242 participants · Phase 1
Study of HQP1351 in Subjects With Refractory CML and Ph+ ALL
- NCT04459000 · 242 participants · NA
Substance Use Treatment and Access to Resources (STARS) Project
- NCT05644496 · 242 participants · Phase 4
ZYNRELEF for Pain Management in Total Knee Arthroplasty
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia